KWM
TWST icon

Kingsview Wealth Management’s Twist Bioscience TWST Stock Holding History

Kingsview Wealth Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,763
Closed -$291K – 1015
2021
Q4 		$291K Sell
3,763
-153
-4% -$15.7K 0.01% 743
2021
Q3 		$419K Buy
3,916
+70
+2% +$8.02K 0.02% 599
2021
Q2 		$506K Sell
3,846
-45
-1% -$5.23K 0.03% 554
2021
Q1 		$475K Buy
3,891
+310
+9% +$47.1K 0.03% 517
2020
Q4 		$506K Buy
3,581
+227
+7% +$25.2K 0.04% 444
2020
Q3 		$255K Buy
+3,354
New +$209K 0.02% 513

Other funds holding TWST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kingsview Wealth Management's TWST Position: Q1 2022 in Review

Kingsview Wealth Management sold out of Twist Bioscience (TWST) in Q1 2022, closing a stake of 3,763 shares — an estimated $291K sold.

Kingsview Wealth Management first reported a position in TWST in Q3 2020 and held it in 6 quarters. The position peaked at $506K in Q2 2021. 212 funds tracked by Wall St. Rank hold TWST as of Q1 2022.

  • Kingsview Wealth Management reported no remaining Twist Bioscience position as of Q1 2022 after selling out during the quarter.
  • Kingsview Wealth Management sold 3,763 Twist Bioscience shares in Q1 2022, an estimated $291K.
  • Kingsview Wealth Management first reported a position in Twist Bioscience in Q3 2020 and held it in 6 quarters.
  • Kingsview Wealth Management's Twist Bioscience position peaked at $506K in Q2 2021.
  • 212 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2022.

Based on Kingsview Wealth Management's 13F filing for Q1 2022, filed 8 Feb 2024.